Indication CINRYZE® (C1 esterase inhibitor [human]) is indicated for routine prophylaxis against angioedema attacks in adults, adolescents and pediatric patients (6 years of age and older) with Hereditary Angioedema (HAE).
When you prescribe CINRYZE for your patient, Takeda Patient Support is here for them. Our support specialists provide several services, including:
Benefits investigation to help determine your patient’s insurance benefits and eligibility for certain services
Specialty pharmacy (or site of care) triage and coordination (if available)
Enrollment in the Takeda Patient Support Co-Pay Assistance Program, if they qualify*
Arrange for Takeda product administration training (at home, if requested by your office) and education for your patient
Information about financial assistance options for your patient, if they‘re eligible.*
*To be eligible, your patient must be enrolled in Takeda Patient Support and have commercial insurance. Other terms and conditions apply. Contact us for more details.
Need assistance?
Our support specialists are never more than a tap or a call away—Monday through Friday, 8:30 AM to 8:00 PM ET.
Need to enroll your patient? Visit TakedaPatientSupport.com/HCP for more information. You can enroll your patient by faxing the completed Start Form.
If English is not your patient’s preferred language, we may be able to assist them in a language of their choosing.
Complete the form with your patient and fax it to 1-866-888-0660.